NEW MEDICINES, NOVEL INSIGHTS
Achieving patient-guided drug development
Download the executive summary
Developing effective, patient-focused therapies that deliver meaningful benefits begins early in development and includes patient insights at every step.
Parexel experts offer solutions that keep a sharp and sustained focus on patients.
IN THIS REPORT
SECTION 1
Integrated Development
Four solutions to include the patient perspective in early decision-making.
Go to section
SECTION 2
Advancing PRO Data
What does it take to generate regulatory-grade patient-reported data?
Go to section
SECTION 3
Diversity Strategies
Inclusive strategies for underrepresented patient groups.
Go to section
Contributing Experts
Emily Brouwer, M.P.H., PharmD, Ph.D., FISPE
Vice President, Epidemiology & Real-World Science
Jakki James
Senior Director, Patient Communications
Jep Poirrier, Ph.D.
Executive Director, Health Economics and Outcomes Research
Katja Rudell
Senior Director, Clinical Outcomes Assessment, Parexel International
Ned Wydysh
Vice President, Oncology and Cell and Gene Therapy Practices, Health Advances
Rachel Smith
Executive Director, Rare Disease, Center of Excellence
Sangeeta Budhia
Vice President, Pricing & Market Access
Stacy Hurt, M.H.A., M.B.A.
Chief Patient Officer
Vera Zheng
Senior Vice President, Asia/Pacific Strategy and Head of Greater China, Parexel International
Xoli Belgrave
Senior Director, Head of Clinical Trial Diversity and Inclusion
Contributing Experts
Emily Brouwer, M.P.H., PharmD, Ph.D., FISPE
Vice President, Epidemiology & Real-World Science
Jakki James
Senior Director, Patient Communications
Jep Poirrier, Ph.D.
Executive Director, Health Economics and Outcomes Research
Katja Rudell
Senior Director, Clinical Outcomes Assessment, Parexel International
Ned Wydysh
Vice President, Oncology and Cell and Gene Therapy Practices, Health Advances
Rachel Smith
Executive Director, Rare Disease, Center of Excellence
Learn what's possible now
Stay current with novel thinking and actionable insights from our experts.
Parexel solutions for patient-guided drug development
Patient-guided drug development requires more than a 30-minute meeting with patient advocates or aspirational text on a website. It is a systematic approach that begins at the earliest stages of development and informs nearly every decision afterward. Our Office of the Patient helps sponsors make use of patient insights to navigate an increasingly complex reimbursement landscape, mitigate risks, and develop commercially viable products that deliver relevant patient benefits.